tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Eun Yang, 98 are a BUY (73.13%), 31 are a HOLD (23.13%), 5 are a SELL (3.73%).
Analyst Eun Yang, currently employed at JEFFERIES, carries an average stock price target met ratio of 59.04% that have a potential upside of 34.69% achieved within 301 days.
Eun Yang’s has documented 257 price targets and ratings displayed on 29 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on RIGL, Rigel Pharmaceuticals at 07-May-2025.
Analyst best performing recommendations are on CNTA (CENTESSA PHARMACEUTICALS PLC ADR).
The best stock recommendation documented was for RIGL (RIGEL PHARMACEUTICALS) at 6/8/2022. The price target of $10 was fulfilled within 9 days with a profit of $2.99 (42.65%) receiving and performance score of 47.39.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold
$42
$-2.15 (-4.87%)
$42
2 years 10 months 8 days ago
(15-Feb-2023)
0/15 (0%)
$-2.18 (-4.93%)
Buy
$42
$-2.15 (-4.87%)
$82
2 years 11 months 12 days ago
(11-Jan-2023)
0/4 (0%)
$-2.1 (-4.76%)
Buy
$42
$-2.15 (-4.87%)
$68
2 years 11 months 12 days ago
(11-Jan-2023)
0/3 (0%)
$-2.1 (-4.76%)
Hold
$55
2 years 11 months 12 days ago
(11-Jan-2023)
0/1 (0%)
$36.77 (201.70%)
Hold
$42
$-2.15 (-4.87%)
$61
2 years 11 months 14 days ago
(09-Jan-2023)
0/2 (0%)
$-1.85 (-4.22%)
What Year was the first public recommendation made by Eun Yang?
